Bayer AG (BAYRY)
OTC: BAYRY
· Real-Time Price · USD
7.54
0.01 (0.13%)
At close: Jun 06, 2025, 3:59 PM
Bayer Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.73B | 9.97B | 11.14B | 13.77B | 11.86B | 10.34B | 11.04B | 14.39B | 12B | 11.28B | 12.82B | 14.64B | 11.12B | 9.78B | 10.85B | 12.33B |
Cost of Revenue | 5.72B | 5.09B | 4.99B | 5.46B | 4.49B | 4.81B | 4.72B | 5.73B | 4.77B | 4.25B | 5.68B | 5.18B | 3.69B | 3.89B | 4.55B | 4.7B |
Gross Profit | 6.01B | 4.88B | 6.15B | 8.3B | 7.38B | 5.53B | 6.33B | 8.66B | 7.23B | 7.03B | 7.14B | 9.46B | 7.43B | 5.89B | 6.31B | 7.63B |
Operating Income | 3.53B | -3.82B | 930M | 3.25B | 2.93B | -3.49B | -938M | 3.08B | 850M | 1.24B | 180M | 4.26B | 1.61B | 530M | -2.28B | 3.15B |
Interest Income | 114M | 150M | 95M | 161M | 249M | 140M | 63M | 148M | 181M | 81M | 50M | 67M | 127M | 29M | 271M | 98M |
Pretax Income | -481M | -4.35B | -97M | 2.6B | 1.69B | -4.3B | -1.57B | 2.61B | 870M | 601M | -523M | 3.72B | 1.5B | 194M | -2.38B | 2.73B |
Net Income | -335M | -4.18B | -34M | 2B | 1.34B | -4.57B | -1.89B | 2.18B | 611M | 546M | -289M | 3.29B | 1.16B | 85M | -2.33B | 2.09B |
Selling & General & Admin | 4.33B | 3.73B | 3.72B | 3.63B | 3.37B | 3.6B | 3.69B | 4.05B | 4.43B | 4.08B | 4.47B | 3.94B | 4.29B | 3.77B | 3.75B | 3.52B |
Research & Development | 1.73B | 1.56B | 1.5B | 1.43B | 1.07B | 1.5B | 1.23B | 1.57B | 1.61B | 1.58B | 1.93B | 1.45B | 1.01B | 1.56B | 1.64B | 1.2B |
Other Expenses | -3.59B | -406M | n/a | n/a | n/a | n/a | n/a | 60M | -561M | 180M | 570M | -148M | -3.45B | 34M | 3.2B | n/a |
Operating Expenses | 2.47B | 4.88B | 5.22B | 5.05B | 4.44B | 9.12B | 7.28B | 5.68B | 5.48B | 5.83B | 6.97B | 5.25B | 1.86B | 5.36B | 8.59B | 4.55B |
Interest Expense | 385M | 642M | 682M | 648M | 752M | 805M | 636M | 478M | 325M | 637M | 703M | 537M | 119M | 332M | 475M | 420M |
Selling & Marketing Expenses | 3.6B | 3.16B | 3.36B | 3.25B | 2.84B | 3.05B | 3.2B | 3.39B | 3.71B | 3.36B | 3.74B | 3.28B | 3.5B | 3.02B | 2.96B | 2.88B |
Cost & Expenses | 8.2B | 9.97B | 10.21B | 10.52B | 8.93B | 13.94B | 12B | 11.42B | 10.25B | 10.08B | 12.65B | 10.43B | 5.54B | 9.25B | 13.13B | 9.24B |
Income Tax Expense | -153M | -153M | -71M | 589M | 302M | 280M | 315M | 424M | 261M | 49M | -234M | 428M | 327M | 104M | -52M | 645M |
Shares Outstanding (Basic) | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.92B | 3.93B |
Shares Outstanding (Diluted) | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B | 3.93B |
EPS (Basic) | -0.09 | -1.06 | -0.01 | 0.51 | 0.34 | -1.16 | -0.48 | 0.56 | 0.16 | 0.14 | -0.07 | 0.84 | 0.30 | 0.02 | -0.59 | 0.53 |
EPS (Diluted) | -0.09 | -1.06 | -0.01 | 0.51 | 0.34 | -1.16 | -0.48 | 0.56 | 0.16 | 0.14 | -0.07 | 0.84 | 0.30 | 0.02 | -0.59 | 0.53 |
EBITDA | 1.67B | 1.06B | 1.76B | 4.37B | 3.34B | -2.48B | 2.35B | 4.19B | 2.39B | 2.38B | 1.28B | 5.36B | 3.17B | 1.42B | -1.05B | 4.24B |
EBIT | -96M | -3.71B | 585M | 3.24B | 2.44B | -3.49B | -893M | 3.12B | 1.68B | 1.28B | 219M | 4.28B | 1.62B | 559M | -2.01B | 3.18B |
Depreciation & Amortization | 1.77B | 4.76B | 1.14B | 1.11B | 900M | 976M | 989M | 1.07B | 704M | 1.1B | 1.07B | 1.08B | 1.02B | 865M | 957M | 1.06B |